Monstarlab Inc.

As of June 30, 2026, Monstarlab Inc. carries a market capitalization of 4.66B, placing it among publicly traded companies globally. Its enterprise value stands at 6.76B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Monstarlab Inc.'s next confirmed earnings release is scheduled for November 13, 2026.

As of June 30, 2026, Monstarlab Inc. has 64.66M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Monstarlab Inc. maintains a current ratio of 2.07, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, Monstarlab Inc.'s stock has declined approximately 59.44% over the past 52 weeks. The 50-day moving average sits at 85.86, while the 200-day moving average is 106.79.

As of June 30, 2026, Monstarlab Inc. holds 3.70B in cash and equivalents against 5.85B in total debt, resulting in a net debt position of 2.08B. Total book value stands at 660.67M, with working capital of 2.65B providing operational flexibility.